We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mutation That Causes Growth-Hormone Deficiency Prevents Cancer and Diabetes

By LabMedica International staff writers
Posted on 10 Mar 2011
Print article
A mutation causing abnormally low growth-hormone activity appears to be responsible for eliminating diabetes and cancer in an isolated community located on the slopes of the Andes Mountains of Ecuador.

A study published in the February 16, 2011, issue of the journal Science Translational Medicine reported results obtained by observing the population of growth hormone-deficient individuals for more than 22 years. During this period, health profiles of 100 individuals with Laron syndrome – caused by deficiency in a gene that prevents the body from using growth hormone - and 1,600 relatives of normal stature were monitored.

The results revealed that during 22 years of observation no cases of diabetes and only one nonlethal case of cancer were found in the Laron syndrome subjects. In comparison, among normal sized relatives living in the same towns during the same period, 5% were diagnosed with diabetes and 17% with cancer. Reduced insulin concentrations and a very low HOMA-IR (homeostatic model assessment–insulin resistance) index in Loran syndrome, indicating higher insulin sensitivity, could explain the absence of diabetes in these subjects.

Serum from Loran syndrome subjects reduced DNA breaks but increased apoptosis in cultures of human mammary epithelial cells treated with hydrogen peroxide. Furthermore, serum from these subjects also caused changes that promoted cellular protection and life-span extension in model organisms.

"The growth hormone receptor-deficient people do not get two of the major diseases of aging. They also have a very low incidence of stroke, but the number of deaths from stroke is too small to determine whether it is significant,” said senior author Dr. Valter Longo, professor of cellular and molecular biology at the University of Southern California (Los Angeles, USA). "Although all the growth hormone deficient subjects we met appear to be relatively happy and normal and are known to have normal cognitive function, there are a lot of strange causes of death, including many that are alcohol related.”

Related Links:

University of Southern California




New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Progesterone Serum Assay
Progesterone ELISA Kit
New
Urine Drug Test
Instant-view Methadone Urine Drug Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.